Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |